I am speechless. Anthem Blue Cross and Blue Shield “peer” denied dara for my patient with NDMM citing no proof that it changes outcomes and did not know know diagnostic criteria for myeloma. Shame on you!

Join us in welcoming Dr. Caitlin Costello Caitlin Costello, MD to the #NashvilleHeme25 faculty! This 2-day CME/CE event is designed to equip you with the latest knowledge in hematology. Secure your spot today: hubs.la/Q02QVK-c0 #CME #CE

Awesome. And clinch at same time! Go friars!

Really looking forward to this!

Oh this is going to be fun! Looking forward to seeing which of us can get more words into one sentence - a faceoff between Weat Coast fast talkers!

Come join me and Vincent Rajkumar with Oncology Brothers at #ash24 with an evening of #MyelomaMusings

Come join us in Hall 6B for some #MyelomaMusings at the Bridging Gaps in Multiple Myeloma Care. Ready to 🎸 with Rahul Banerjee, MD, FACP. Who brought the ☕️?

A wonderful morning to kick off ASH. Myeloma treatment 101 in an hour! Wonderful to be alongside Rahul Banerjee, MD, FACP. Welcome to America’s Finest City - my home! UC San Diego Health

If you think physicians are overpaid, maybe you should take the necessary course work in undergrad, take and pass the MCAT, apply for med schools, pay hundreds of thousands for tuition, learn for 4 years in a very high pressure learning environment, then pay thousands more to

CONGRESS | #ASH24 | POSTER Caitlin Costello Caitlin Costello, MD, UCSD Moores Cancer Center, shares results from the optimized lymphodepletion cohort (N = 21) of a phase I study of P-BCMA-ALLO1, a BCMA-directed CAR-T in RRMM. P-BCMA-ALLO1 demonstrates a promising ORR and favorable

AURIGA study results: - D-R maintenance improved MRD-conversion rate in NDMM patients who were MRD+ after transplant vs R maintenance. - PFS favored D-R maintenance, with an improved 30-month PFS rate vs R alone; D-R was well tolerated Plasma Cell Pete Caitlin Costello, MD #mmsm

🚨 Last Call! One week away! Join us at San Diego for #BTFHemBreast25 🚨Register NOW: buff.ly/40r1YxG 🌟8.50 ABIM MOC II / AMA PRA Category 1 Credit™ / Nursing Contact Hours ☕Network in-person with hematology & breast cancer experts from UC San Diego Health Moores Cancer Center OHSU Knight Cancer Institute

Really looking forward to co-chairing this with @AaronGoodman33 this weekend. Come join us!

The NHC Debate Club at #NashvilleHeme25 is ready to bring the heat! Get ready for an "after-school" style showdown where our expert debaters will tackle the hottest topics in hematologic malignancies. You won't want to miss these engaging discussions! Join us at the 2-day CE

The great debate begins between Natalie Callander and Dr. Amrita Krishnan moderated by Rahul Banerjee, MD, FACP - to transplant or not to transplant in NDMM? Let the greatest debater win! Nashville Hematology Conference

What a fantastic panel this was! How to improve patient access and experience? Who cares for the caregivers? Thank you to All4Cure and HealthTree Foundation for improving patient lives and supporting investigator research and trial enrollment.

Glad to share our upcoming interactive educational program ‘Paving the Way for Optimal Utilization of Early CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma’

Grateful to #curebound and San Diego Padres for supporting so many people with cancer. We will find the cure! Elton John UC San Diego Health Moores Cancer Center